VOLUSON E10 BT19

Device GE HEALTHCARE
Total Payments
$24,063
Transactions
2
Doctors
0
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2019 $24,063 2 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $24,063 2 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
THE USE OF 3D ULTRASOUND AND POWER DOPPLER IN ASSESSING BLOOD FLOW IN THE UTERINE RADIAL AND SPIRAL ARTERIES TO THE ENDOMETRIUM IN FRESH VS FROZEN EMBRYO TRANSFERS AND CORRELATION WITH OUTCOMES GE HEALTHCARE $22,616 0
THE USE OF 3D ULTRASOUND AND POWER DOPPLER IN ASSESSING BLOOD FLOW IN THE UTERINE RADIAL AND SPIRAL ARTERIES TO THE ENDOMETRIUM IN FRESH VS FROZEN EMBRYO TRANSFERS AND CORRELATION WITH OUTCOMES GE Healthcare $1,447 0

Top Doctors Receiving Payments for VOLUSON E10 BT19

Doctor Specialty Location Total Records
Unknown Norfolk, VA $24,063 2

About VOLUSON E10 BT19

VOLUSON E10 BT19 is a device associated with $24,063 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is GE HEALTHCARE.

Payment data is available from 2019 to 2019. In 2019, $24,063 was paid across 2 transactions to 0 doctors.

The most common payment nature for VOLUSON E10 BT19 is "Unspecified" ($24,063, 100.0% of total).

VOLUSON E10 BT19 is associated with 2 research studies, including "THE USE OF 3D ULTRASOUND AND POWER DOPPLER IN ASSESSING BLOOD FLOW IN THE UTERINE RADIAL AND SPIRAL ARTERIES TO THE ENDOMETRIUM IN FRESH VS FROZEN EMBRYO TRANSFERS AND CORRELATION WITH OUTCOMES" ($22,616).